CYB003/CYB004 clinical catalysts into 2026, $248M cash runway, equity raises risk, valuation optionality. Click for this CYBN update.

We recently compiled a list of the 12 Best Psychedelic Stocks to Buy in 2025. In this article, we are going to take a look at where Cybin Inc. (NYSEAMERICAN:CYBN) stands against the other psychedelic ...

Cybin Inc., now operating as Helus Pharma, has rebranded and moved its U.S. listing from NYSE American to Nasdaq under the ...

TORONTO--(BUSINESS WIRE)--Cybin Inc. (NYSE American:CYBN) (NEO:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing ...

TORONTO--(BUSINESS WIRE)--Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry platform company committed to revolutionizing mental ...

Positive Clinical Progress: Cybin Inc. has reported significant advancements in its clinical programs, notably achieving a primary efficacy endpoint in its Phase 2 study of CYB003 for treating Major ...

Cybin ( ($TSE:CYBN) ) has provided an announcement. Helus Pharma, the new operating name of Cybin Inc., has rebranded to better reflect its ...

- EMBARK for Clinical Trials (“EMBARKCT”) being developed as a scalable model of psychedelic facilitation training to support future pivotal studies - - American Medical Association (“AMA”)’s new CPT ...

- Strategic Partnership Agreements promote collaboration and aligned incentives across sites, enhancing operational efficiency and improving site performance and patient recruitment - - Phase 2 data ...

--Newly acquired novel psychedelic molecules diversify Cybin’s development portfolio, providing access to multiple future indications-- --Adelia brings a range of technologies related to novel ...

Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options ...

Visit a quote page and your recently viewed tickers will be displayed here. Eric So is the founder of Globalive Technology Partners, Inc. (founded in 2017), Cybin, Inc. (founded in 2016), and Cybin ...